Registry for Primary Ciliary Dyskinesia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03271840|
Recruitment Status : Recruiting
First Posted : September 5, 2017
Last Update Posted : October 18, 2018
Primary Ciliary Dyskinesia (PCD) is a rare disease, which means that any single PCD center has experience with a limited number of patients. PCD Registry is the collection of data about PCD from many centers and countries who treat children with PCD. Collecting data about PCD increase the knowledge on PCD, better describe the course of the disease, and help to better understand the progression of the disease and be used to develop new treatments.
In the PCD registry of Alberta, important information about PCD such as time of diagnosis, symptoms, and tests which led to the diagnosis, state of health at diagnosis, the progression of lung function, the occurrence of severe infections, tests and treatments data will be collected from the patients' medical records.
|Condition or disease|
|Primary Ciliary Dyskinesia|
In order to better characterize the clinical course, and improve the diagnosis and treatment of PCD, the investigators propose to establish a provincial PCD registry in Alberta. This registry will be securely linked to the currently existing International Registry for PCD and will allow more researchers to use the information to do research on PCD.
The investigators will collect demographic data: current age, sex, age, diagnostic findings and symptoms at diagnosis; in addition, clinical data about PCD which are recorded during the past and future clinical visits and encounters (e.g. lung function, weight, height, infections, treatments, and complications) will also be collected.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||30 participants|
|Target Follow-Up Duration:||10 Years|
|Official Title:||Registry for Primary Ciliary Dyskinesia: : Systematic Data Collection on Incidence, Clinical Presentation, Treatment and Course of the Disease|
|Actual Study Start Date :||August 26, 2017|
|Estimated Primary Completion Date :||January 2030|
|Estimated Study Completion Date :||December 31, 2030|
- Age of diagnosis [ Time Frame: 2017-2030 ]Years
- Lung Function [ Time Frame: 2017-2030 ]% predicted for age
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03271840
|Contact: Israel Amirav, M.Demail@example.com|
|University of Alberta||Recruiting|
|Edmonton, Alberta, Canada, T6G2C6|
|Contact: Israel Amirav 7808840296 firstname.lastname@example.org|
|Principal Investigator:||Israel Amirav, MD||University of Alberta|